Total Funding
28
26
Total FundingSeries C raised
Growth Score
-6 pts
Heat Score
-19 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
42565
GI Innovation is a global leader of microbiome drug development.
- Nari Yun: Head of clinical strategy
- Myeong-ho Jang: Founder and CEO
About the Company
GI Innovation is a South Korean bio-venture company, integrating basic science and translational innovation in developing biologics for patients around the world. GI Innovation’s strategic focus is on immuno-oncology and inflammation/immunology diseases. GI Innovation has established GI-SMART platform technology that is designed to accelerate
the development of biologics through the efficient optimization of multi-targeting fusion protein therapeutics with high quality and high productivity.
